So far in 2022, IPO activity has been dominated by small, volatile issuers. Of the year’s 51 pricings to date, 19 (37%) have soared 100% or more in their debuts, while one-in-ten have jumped at least 500%. But those with the largest first-day pops have...read more
Four IPOs raised $266 million this week, headlined by norovirus vaccine developer HilleVax (HLVX). The other three deals were micro-caps, an area of the IPO market that continues to see rapid price swings thanks to interest from momentum...read more
The US IPO market reached a 52-week low on Wednesday, measured by the Renaissance IPO Index (tracker for the IPO ETF, NYSE: IPO). You wouldn't know it by looking at Wednesday's new...read more
Tenon Medical, which is launching a surgical implant system for sacroiliac joint fusion procedures, raised $16 million by offering 3.2 million shares at $5, the midpoint of the range of $4.50 to $5.50. The company offered 0.8 million fewer shares than previously...read more
2022 IPOs with the largest first-day pops are now some of the worst performers
So far in 2022, IPO activity has been dominated by small, volatile issuers. Of the year’s 51 pricings to date, 19 (37%) have soared 100% or more in their debuts, while one-in-ten have jumped at least 500%. But those with the largest first-day pops have...read more
US IPO Weekly Recap: 4 IPOs price, led by norovirus biotech HilleVax
Four IPOs raised $266 million this week, headlined by norovirus vaccine developer HilleVax (HLVX). The other three deals were micro-caps, an area of the IPO market that continues to see rapid price swings thanks to interest from momentum...read more
Two more micro-cap IPOs pop on Wednesday, even as US IPO market hits 52-week low
The US IPO market reached a 52-week low on Wednesday, measured by the Renaissance IPO Index (tracker for the IPO ETF, NYSE: IPO). You wouldn't know it by looking at Wednesday's new...read more
Surgical implant maker Tenon Medical prices downsized IPO at $5 midpoint
Tenon Medical, which is launching a surgical implant system for sacroiliac joint fusion procedures, raised $16 million by offering 3.2 million shares at $5, the midpoint of the range of $4.50 to $5.50. The company offered 0.8 million fewer shares than previously...read more